AmplifyBio Chooses Blue Mountain to Achieve GMP Compliance and Advance Digital Strategy
Retrieved on:
Thursday, December 1, 2022
Toxicology, Quality, Title 21 CFR Part 11, Good manufacturing practice, CCMS, Calibration, GxP, Patient, Medical device, CFR, Maintenance, Gene therapy, Disease, GMP, Reliance Institute of Life Sciences, Software as a service, EAM, Cell, Mobile enterprise asset management, Computerized maintenance management system, CMMS, Safety, RAM, Fine chemical, Gemstone, Risk management, Biotechnology, Medication
STATE COLLEGE, Pa., Dec. 1, 2022 /PRNewswire/ -- AmplifyBio has selected Blue Mountain Regulatory Asset Manager (RAM) to help with incorporating industry best practices and ensuring electronic records compliance.
Key Points:
- STATE COLLEGE, Pa., Dec. 1, 2022 /PRNewswire/ -- AmplifyBio has selected Blue Mountain Regulatory Asset Manager (RAM) to help with incorporating industry best practices and ensuring electronic records compliance.
- In one seamlessly integrated system, Blue Mountain RAM provides world-class calibration and maintenance management, all while ensuring GxP compliance.
- To learn more about AmplifyBio, visit https://www.amplify-bio.com/
About Blue Mountain Quality Resources:
Leading the Life Sciences in GMP asset management for 30+ years, Blue Mountain offers deep Life Sciences domain expertise. - To learn more about Blue Mountain, visit: https://coolblue.com
For more information, contact Akashi Perera at 814-234-2417 or [email protected].